Geoff’s Narrations
The GIST
The Weblog


Excited by a renewed give attention to viruses, Dr. Klimas hopes to open a Middle of Excellence to review and deal with viral reactivation.
The Dr. Klimas interview is the following in a sequence of “What’s Up, Doc?” video interviews the place I ask specialists within the ME/CFS/FM and long-COVID fields what’s thrilling them proper now.
You’ll be able to watch the video right here. (I forgot to show off the recording, leaving the final 5 minutes of it scanning the ceiling of my trailer… Whoops! I couldn’t edit that half as a result of the video sits on the Nova Southeastern College web site.)
The weblog beneath goes over the discuss and provides in issues right here and there…
You’re at all times assured a stimulating dialog with Nancy Klimas. It’s not simply that she’s a researcher – she’s additionally a physician and longtime persistent fatigue syndrome (ME/CFS) advocate. From the IACFS/ME to CFSAC – the previous federal ME/CFS Advisory Panel – to many working teams, she’s participated in nearly all the things doable. It got here as no shock that once I requested her about what’s thrilling now within the ME/CFS/lengthy COVID subject, she targeted not on her work however on the sector at giant.
Taking the long-range view, she returned to her first ME/CFS paper from 34 years in the past (on the time of the interview), “Immunologic abnormalities in persistent fatigue syndrome”. Persistent immune activation, NK cell defects, viral reactivation – we’re nonetheless speaking about all of these (and have now added immune senescence – a brand new time period).
THE GIST
From researcher to physician, to serving on many ME/CFS panels and dealing teams, Dr. Nancy Klimas has been within the thick of issues for many years. Provided that, it wasn’t all that shocking that when requested about what’s thrilling her now within the ME/CFS subject, she targeted not on her work however on the sector at giant.
Taking a long-range view, she returned to her first ME/CFS paper from 34 years in the past, which discovered persistent immune activation, immune cell exhaustion, and viral reactivation – all of which researchers are nonetheless learning however in a lot higher depth now.
As Nancy talked, the failure of the NIH, particularly, to offer ample funding got here into focus. Stephen Strauss’s dedication, after his small trial of acyclovir – which isn’t notably efficient towards the Epstein-Barr virus – failed, that the Epstein-Barr virus (EBV) was not concerned in ME/CFS successfully shut down analysis into viral reactivation for years on the NIH.
Constant findings of EBV reactivation through the early levels of a coronavirus an infection, and its constant emergence in lengthy COVID, have modified the image dramatically, nevertheless. EBV is now an enormous deal, and that’s good, however Dr. Klimas additionally identified that HHV-6 – which is reactivated as a lot, if no more, in her sufferers – is hardly being studied.
Persistent viral reactivation means persistent immune overdrive, and Dr. Klimas stated that if any ailments exhibited persistent immune overdrive, they had been ME/CFS and lengthy COVID. That persistent immune activation comes at a value, and that’s immune senescence – a gentle degradation of the immune system’s capability to manage.
So, what makes Dr. Klimas excited is the renewed give attention to viruses and the immune system as remedy targets. She hopes to create a “Middle of Excellence for Viral Reactivation and Human Illness” that may analysis viral reactivation and deal with it and that brings us to Dr. Klimas’s greatest want for ME/CFS – a scientific trials community for ME/CFS.
A scientific trials community for ME/CFS is Dr. Klimas’s best choice in her “Desperately Wanted” class. It would slot in the “let’s lastly get severe about treating ME/CFS strategy” class.
Scientific trial networks are designed to provide an optimum mix of rigor and effectivity. They’re the antidote to the small, underpowered, disorganized scientific trials which have pervaded ME/CFS analysis and haven’t supplied a lot assist. The advantages are voluminous: improved affected person recruitment, a streamlined strategy, the necessity for just one placebo group, higher information high quality, centralized databases, and shared finest practices imply diminished prices and extra dependable outcomes.
A scientific trials community would imply “good trials”: trials that focus on subsets as a substitute of ME/CFS sufferers at giant – one thing Dr. Klimas believes is the important thing to success on this illness. A Rituximab trial, as an illustration, would give attention to ME/CFS sufferers with indicators of autoimmunity as a substitute of taking all comers.
Dr. Klimas stated that if she had a terrific benefactor, she “would slam some severe {dollars}” into making a scientific trials community. 🙂
With that, we turned to her long-delayed ME/CFS trial and came upon that it isn’t a reproduction of her GWI trial. First, word that the trial is designed to be healing; i.e., it was what supercomputer modeling prompt might return folks with ME/CFS to homeostasis or well being.
With the excessive charges of testosterone deficiency she sees in males with ME/CFS, she is going to first normalize the intercourse hormones, then try and cease mind irritation with etanercept (Enbrel), then reset the HPA axis and cease the irritation utilizing mifepristone. The trial both has begun or will start quickly.
Dr. Klimas is taking a staggered three-drug strategy to ME/CFS, however she’s leaving open the chance that the best antiviral might do the trick…
If ME/CFS is like HIV, attributable to a pathogen that persists within the physique, theoretically, it might merely be cured by eliminating the virus. Antiviral trials have been few and much between, however Martin Lerner’s and Jose Montoya’s work suggests antivirals might be useful. Regardless of all of the curiosity in herpesviruses, the previous 30 or 40 years haven’t introduced us any randomized, placebo-controlled scientific trials.
Whereas the present crop of antiherpesvirus medicine isn’t notably efficient, some drug candidates are being examined for different ailments. Dr. Klimas’s monoclonal antibody (mAB) case sequence produced unimaginable outcomes with lengthy COVID – and a minimum of 10 mAB research focusing on EBV are underway. One other drug Dr. Klimas finds notably engaging is Moderna’s anti-EBV vaccine, which is in section I testing now – and which she hopes, sooner or later, to attempt testing in her sufferers.
A mannequin produced by Dr. Klimas’s chief computational biologist, Travis Craddock, discovered that combining Rituximab with a herpesvirus drug was in a position to knock down EBV for lengthy intervals of time. Makes an attempt to make use of antivirals alone allowed EBV to rapidly roar again.
Dr. Klimas additionally seems ahead to the breakthroughs she believes synthetic intelligence and different technique of advanced information evaluation will deliver. Her workforce’s supercomputer assesses information randomly and in each route doable utilizing chaos concept in order that no chance escapes it.
An electronic mail right now indicated that the Institute for Neuro-Immune Drugs has teamed up with Conquer CFS to offer folks with ME/CFS with two months of free entry to the Conquer CFS Emergency Reset course created by Max Kennedy – a former individual with ME/CFS – along side Dr. Jenny Jin, an CFS/Fibromyalgia and Ache Administration Skilled. Learn the way on the backside of the weblog.
The findings from the primary actual dive into ME/CFS sufferers’ immunology – which was carried out on simply 30 ME/CFS sufferers/with no wholesome controls – have held up. A “deficiency of mobile immune functioning that was current in all topics” prompt, “that CFS is a type of acquired immunodeficiency”. The immunological sample was “appropriate with a persistent viral reactivation syndrome”.
(Sure, 35 years later, we’re speaking a couple of comparable paradigm, however look how far this nonetheless very small subject has come. NK cells are not the massive focus, however now the actually heavy hitters of the adaptive immune response—T and B cells—are. Researchers now imagine that the failure of those cells could have triggered the innate and extra inflammatory arm of the immune system to step in and try and compensate.
(Why these immune cells have failed is not such a thriller, both. Research recommend that an lack of ability to provide ample quantities of power will be the trigger—a pleasant discovering given the general power manufacturing issues in ME/CFS. Plus, there’s a brand new participant on the town. Immune senescence/exhaustion wasn’t a factor again within the 90s, however it’s now and has been present in NK, T, and B cells in ME/CFS.)
As Nancy talked, the failure of the NIH, particularly, to offer ample funding got here into focus. Anthony Fauci performed a distinguished position in that when he solid the small ME/CFS analysis program out into the wilderness and closed down its three small facilities—considered one of which was led by Nancy.
Whereas Stephen Strauss was one of many first researchers to push for a severe examine of ME/CFS, Strauss’s dedication, after his small acyclovir trial failed, that Epstein-Barr virus was not concerned in ME/CFS successfully shut down analysis into viral reactivation for years on the NIH. (At one level, the NIH flat-out acknowledged it could not assist any analysis into pathogens in ME/CFS.)
Dr. Klimas famous that acyclovir isn’t notably efficient towards EBV however that more practical medicine have extra issues of safety. (The present crop of EBV medicine (acyclovir, valacyclovir, and ganciclovir) solely have an effect on the virus when it’s replicating; i.e. when it’s in its “lytic section”. Even in its latent section, nevertheless, EBV could cause most cancers and autoimmune illness.)
Constant findings of EBV reactivation through the early levels of a coronavirus an infection and its constant emergence in lengthy COVID have modified the image dramatically. EBV is now an even bigger focus. With the massive bug’s capability to mess up immune functioning, induce autoimmunity, and trigger most cancers, and its lengthy historical past in ME/CFS, Dr. Klimas puzzled why its reactivation in lengthy COVID has come as a shock.


Dr. Klimas finds that HHV-6 is as usually reactivated in her sufferers as EBV. It has solely hardly ever been studied…
HHV-6 is one other matter. Dr. Klimas finds numerous HHV-6 reactivation in ME/CFS – maybe greater than EBV – but it has been just about ignored in each ME/CFS and lengthy COVID. (My lab checks confirmed excessive ranges of HHV-6 however no EBV reactivation.) Prior to now 12 months, a number of research have linked HHV-6 to ME/CFS and a pair to lengthy COVID. John Chia’s enterovirus findings current one other intriguing pathogen chance that has not acquired its due.
Noting that our immune programs have backup upon backup programs, Dr. Klimas stated anytime you see a virus escape, issues are damaged. We’re studying extra about viral reactivation on a regular basis. The coronavirus was by no means thought to provide a latent an infection, however intestine research recommend that in some folks, the coronavirus is certainly nonetheless current.
A damaged immune system doesn’t imply the immune system stops attempting to get on the virus. The truth is, a minimum of for a time, it could be attempting tougher than ever. Dr. Klimas stated if there have been ever diseases in persistent immune overdrive, they had been ME/CFS and lengthy COVID. That persistent immune activation comes at a value, and that’s immune senescence.
Immune senescence has usually been related to ageing, however some findings (T, B, and NK cell dysregulation, viral reactivation, persistent irritation, telomere shortening) recommend that the immune programs in folks with ME/CFS are ageing extra quickly than regular as properly.
So, what makes Dr. Klimas excited is the renewed give attention to viruses and the immune system as remedy targets. She hopes to create a “Middle of Excellence for Viral Reactivation and Human Illness” that may analysis viral reactivation and deal with it – which brings us to Dr. Klimas’s greatest want for ME/CFS.
“Desperately Wanted”- A Scientific Trials Community
A scientific trials community for ME/CFS is Dr. Klimas’s best choice in her “Desperately Wanted” class. It would slot in the “let’s lastly get severe about treating ME/CFS strategy” class.
Scientific trial networks are designed to provide an optimum mix of rigor and effectivity. They’re not straightforward to construct – it took Klimas and firm three years to provide the protocols, standards, major/secondary outcomes, and so forth., wanted for the Gulf Struggle Sickness scientific trials community. As soon as they had been carried out, although, the trials might transfer ahead successfully and effectively.
Improved affected person recruitment, a streamlined strategy, the necessity for just one placebo group, higher information high quality, centralized databases, and shared finest practices imply diminished prices and extra dependable outcomes. With that comes extra funding alternatives, as public establishments, personal foundations, and pharmaceutical firms usually tend to fund trials in that setting.
They’re the antidote to the small, underpowered, disorganized scientific trials which have pervaded ME/CFS analysis and haven’t supplied a lot assist. Nobody can rely on – or is aware of what to make of – a small scientific trial that makes use of completely different standards from different trials to decide on its sufferers, completely different end result measures to evaluate them, and is underpowered in addition.


In a scientific trials community, antiviral trials would goal folks with indicators of viral reactivation.
A scientific trials community for ME/CFS would, Dr. Klimas stated, design good trials – i.e., trials that focus on subsets as a substitute of ME/CFS sufferers at giant – one thing that Dr. Klimas believes would be the key to success on this illness.
As a substitute of taking all comers, because the previous Rituximab trial did, a brand new Rituximab trial would goal ME/CFS sufferers with indicators of autoimmunity. Equally, an antiviral trial would goal sufferers with indicators of viral reactivation, and so forth.
Dr. Klimas stated that if she had a terrific benefactor, she “would slam some severe {dollars}” into making a scientific trials community. It might use the infrastructure produced within the Gulf Struggle Sickness scientific trials community that was funded by the DOD.
When requested, “If a scientific trials community had been beneficial for ME/CFS,” ChatGPT acknowledged one has been “strongly beneficial” by “advocacy teams, researchers, and governmental advisory our bodies.” Whereas ME/CFS is “severely underfunded,” a “scientific trials community might dramatically enhance the tempo of ME/CFS analysis and probably result in the invention of efficient remedies.”
Dr. Klimas’s 2-Stage – No, Make That 3-Stage – ME/CFS Scientific Trial
For now, we have now what we have now, and I needed to ask Dr. Klimas about her long-delayed ME/CFS scientific trial, and when she answered, one thing new popped up – the ME/CFS trial isn’t a reproduction of the GWI sickness trial. Given the testosterone deficiency she usually sees in males with ME/CFS, it wasn’t shocking to see the mannequin say first normalize the intercourse hormones, then cease mind irritation with etanercept (Enbrel), then reset the HPA axis and cease the irritation utilizing mifepristone.


Along with her mannequin exhibiting that testosterone is protecting in males and sometimes poor, Dr. Klimas added testosterone to her ME/CFS scientific trial.
We’ll see how the trial seems, however word that it’s one of many few trials designed to be healing, i.e., to return ME/CFS sufferers’ programs to homeostasis, or normalcy. I believe it received’t be – that’s rather a lot to ask (!) – however since Dr. Klimas will feed the info from the trial again into the pc to strengthen the following mannequin, it ought to transfer the needle ahead.
The testosterone challenge illuminates the typically stunning holes present in ME/CFS analysis. Despite the fact that intercourse hormones should, it appears, play a job within the feminine predominance seen in ME/CFS (and fibromyalgia and lengthy COVID), the position testosterone could also be taking part in in males has been nearly fully ignored. Dr. Klimas’s 2014 examine was the primary to say it in any respect (the examine discovered testosterone was protecting towards ME/CFS), and solely one different paper – revealed final 12 months – has.
Talking of her staggered three-drug strategy to ME/CFS – Dr. Klimas stated you’re most likely not going to treatment this sickness by touching one goal – you’re going to have to the touch a number of. There was a proviso to that, although. She’s leaving open the chance that the best antiviral might do the trick…
An Antiviral Method
If ME/CFS is like HIV, attributable to a pathogen that persists within the physique, theoretically, it might merely be cured by eliminating the virus, however antiviral trials have been few and much between.
Martin Lerner, whom she referred to as “a good looking man” and who cured his personal ME/CFS, “labored like hell to get EBV out of ME/CFS sufferers’ programs,” she stated. As a substitute of relying solely on much less efficient however safer antivirals, Lerner used some big-gun antivirals, rotated his antivirals – and had some good remedy outcomes in addition.


If ME/CFS and lengthy COVID are attributable to persistent viruses, then antivirals might be healing.
(Lerner’s revealed research produced good outcomes however had been, I used to be informed, wanting statistically. Lerner usually used long-duration remedies – as much as a 12 months or extra – and required his sufferers to pay shut consideration to pacing. Well being Rising has a number of Lerner restoration tales on its web site. In a video interview developing, Dr. Henderson in Denver informed me that antivirals took a minimal of three months to work in ME/CFS.)
Jose Montoya at Stanford, in what Dr. Klimas referred to as a really underpowered potential chart evaluate examine, discovered that 81% of sufferers responded cognitively and, importantly, that the longer an individual was handled – the higher the response he/she had. An earlier, very small (n=12) examine discovered that 9/12 sufferers skilled a close to decision of their signs. Notice that each of those trials used a drug – valganciclovir (Valcyte) – which Dr. Klimas characterised as being not notably efficient with EBV.
Regardless of some promising outcomes, a bigger, placebo-controlled section II trial was by no means carried out – one thing Dr. Klimas discovered stunning. Halting EBV reactivation wouldn’t have been in a position to die on the vine, she thought, if ME/CFS had a scientific trials community and a technique to get section II trials (n=50-500 folks) funded. (Part II trials check each the efficacy and the optimum dose of a drug.)
The lengthy and the wanting it’s that regardless of all of the curiosity in EBV and different herpesviruses in ME/CFS, we’ve hardly begun to start out assessing the position antivirals might play.
Knocking EBV Down with a 2-Drug Combo
One other query is: why would we count on one drug to knock out such a posh and chronic virus? Dr. Pridgen’s two-drug strategy to herpesviruses in fibromyalgia is in stage three trials, and Pridgen’s early information prompt that including Paxlovid to it might do properly in lengthy COVID.
Dr. Klimas didn’t point out Travis Craddock’s mannequin of EBV discount, but it surely was fascinating. Craddock discovered that if EBV was current in each epithelial and B-cells (it’s latent in each), that whereas Rituximab might knock down EBV-infected B-cells, the virus would quickly re-emerge from EBV-infected epithelial cells. The one technique to get long-term EBV suppression with one drug was to make use of such excessive doses that it could be poisonous.
Including a timed B-cell remedy to an antiviral drug was completely different – it flatlined the virus for fairly some time. Craddock was persevering with to refine the strategy however stated, theoretically, it might produce a long-term discount in viral load.
Future EBV Medicine
Given Dr. Klimas’s somewhat spectacular early success with monoclonal antibodies (mAB) for lengthy COVID (one other trial ought to have begun by now), I needed to ask if mABs exist for Epstein-Barr virus. Monoclonal antibodies might be efficient towards viruses as a result of they’ll lock onto a virus, goal it for the immune system, and maintain it from coming into cells. mWhile no mABs have, a minimum of ten trials assessing EBV mAB effectiveness towards most cancers are underway.


Dr. Klimas was thinking about attempting out a brand new mRNA vaccine for EBV.
Dr. Klimas was notably thinking about Moderna’s mRNA vaccine for EBV, that’s in section I (security) trials proper now. Moderna is utilizing the identical expertise it utilized in its coronavirus vaccine to alert the immune system to the presence of EBV and assault it: that’s, it triggers the cell to provide proteins related to EBV in order that the immune system will rapidly acknowledge EBV when it reveals up and assault it. Each the mRNA and the proteins produced by the vaccine are rapidly damaged down, leaving the immune system looking out for any viral reactivation.
Dr. Klimas stated that as quickly because the trial was carried out, she could be knocking on Moderna’s door to see in the event that they’re thinking about working together with her.
N of I trials – the Customized Drugs Method and the AI Juggernaut
Dr. Klimas desires to see huge, well-organized scientific trials in ME/CFS, however she additionally desires to do huge, complete N=1 research. Since each individual is completely different, when you collect sufficient information, synthetic intelligence can present remedy plans – first repair this, then do that, after which try this – for people.
Talking of synthetic intelligence, information mining and computational biology – it’ll solely get more practical. The sky is the restrict with regard to information. The three million bits of knowledge per timepoint she and her workforce gave the computational biologists through the train examine didn’t impress them in any respect – they needed extra (and if I’ve the best examine, that was ten years in the past).


Dr. Klimas’s workforce makes use of chaos concept to have a look at information from each doable angle.
Klimas’s workforce makes use of chaos concept of their supercomputer to provide you with solutions. This system assesses the info randomly and in each route doable in order that no chance escapes it – after which supplies fashions her workforce can assess and check.
One purpose we’d like extra NIH-funded research is that about ten years in the past, the NIH required that in the event that they paid for a examine, the uncooked information needed to be made public – so Dr. Klimas is pouring NIH-funded ME/CFS examine information into her dataset. Since Nath’s intramural examine assessed issues nobody else has carried out, the info from that examine might be fairly useful.
Dr. Klimas stated she tried to change into a long-COVID RECOVER scientific heart however apparently failed as a result of her plans included evaluating lengthy COVID and ME/CFS – and that was a no-no. She is within the midst, although, of a giant CDC-funded examine evaluating lengthy COVID and ME/CFS. (In case you are in South Florida and have lengthy COVID, please contact her – she wants extra individuals.)
Institute of Neuro-Immune Drugs Embraces Thoughts/Physique Method
Lastly, Dr. Klimas didn’t point out it, however an electronic mail right now indicated that the Institute for Neuro-Immune Drugs is branching out and has teamed up with Conquer CFS to offer folks with ME/CFS two months of free entry to the Conquer CFS Emergency Reset course created by Max Kennedy – a former individual with ME/CFS – along side Dr. Jenny Jin, an CFS/Fibromyalgia and Ache Administration Skilled.
An increasing number of ME/CFS specialists are together with thoughts/physique/neuroplasticity practices of their remedy protocols. To get 2 months of free entry:
- Click on this hyperlink: https://conquercfs.com/programs.
- Choose “Emergency Reset Course.”
- Please fill out the shape particulars (together with the ‘fee technique’ part). Notice that the hyperlink above supplies you with two months of free entry. A bank card is required in case you determine to subscribe for longer.
- Please electronic mail mcarr1@nova.edu when you’d prefer to obtain an electronic mail reminder on the two-month mark. Presently, you’ll be able to determine whether or not to proceed with a paid subscription or cancel as soon as the free entry expires.
*Replace
ME/CFS On-line Course Response:
“I’m sending a comply with up word to the month-to-month publication our Institute despatched out yesterday that included details about a mind retraining program. I have to say clearly and publicly that we weren’t endorsing this system, we had been merely passing alongside the knowledge. We’re sorry for the confusion we triggered. Usually, as you all most likely know, our institute is a really biologic program engaged on the organic mediators of sickness. That stated, we have now seen in our sufferers that after folks attain a plateau of enchancment it may be useful to some in the event that they do the type of cognitive challenges that make you “rewire your mind” (for lack of a greater time period).
I do know that packages that take note of practising cognitive workout routines that enhance response time, and the pace and effectivity of fundamental mind processes might be useful. Primarily, after you have quieted neuroinflammation and restored environment friendly perfusion — that’s, stopping or slowing any type of injury that’s ongoing — you need to use the mind and nervous system to regrow it. Thus, packages that offer you cognitive workout routines, balancing workout routines, and vagal nerve workout routines are all aimed toward restoring this regular operate by means of neuroplasticity. They assist to develop new cells and join them to the neural community. I might urge you to have a look at any program utilizing cognitive strategies as they’ll differ tremendously, and to know that they complement and don’t substitute the remedy of underlying biologic underpinnings of the sickness”
Institute for Neuro-Immune Drugs
Kiran C. Patel School of Osteopathic Drugs
The Final Days of Well being Rising’s BIG (little) Finish of the 12 months (Starting of the 12 months) Donation Drive!
We’re within the final days of our drive. Because of everybody who has supported Well being Rising to the tune of about $55,000 🙂


We’re getting there! We’re within the final days of our drive! Please assist us – and maintain the knowledge flowing 🙂
Having the ability to discuss to ME/CFS/FM and long-COVID specialists is a crucial function of Well being Rising. Our legacy of rigorous and goal reporting has had a pleasant facet profit – specialists in these fields are prepared to speak to us!
To this point, our “What’s Up, Doc?” sequence has included interviews with Lauren Stiles (Dysautonomia Worldwide), Eleanor Stein MD, Wenzhong Xiao (Open Drugs Basis), and Nancy Klimas (Institute for Neuroimmune Drugs). Talks with Dr. Natelson (neurologist) and Dr. Thomas Henderson might be up shortly, and extra are deliberate. If there’s anybody you need Well being Rising to speak to, please tell us. 🙂
If these sorts of talks are useful to you, please assist us!
Please Assist Well being Rising and Preserve the Info Flowing